BIOL

Q: What is the price of BIOLASE (BIOL) today?

The price of BIOLASE (BIOL) today is $ 0.00, with return of 0% compared to the last year. The price of BIOLASE (BIOL) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of BIOLASE (BIOL) and international markets.

Q: When does BIOLASE (BIOL) pay dividends?

BIOLASE (BIOL) did not distribute dividends in the last year.

Q: Is BIOLASE (BIOL) worth it?

Currently, BIOLASE (BIOL) is priced at $ 0.00, with a P/E of -0.12%, representing a deviation of -222,146% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy BIOLASE (BIOL) stock?

Investing in stocks of BIOLASE (BIOL) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of BIOLASE (BIOL) yield today?

The yield of BIOLASE (BIOL) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of BIOLASE (BIOL) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BIOLASE Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.12

p/bv

-0.51

DIVIDEND YIELD

0.00%

price BIOL

BIOL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of BIOL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BIOL

review the fundamentals of BIOLASE shares

P/E

-0.12

Sector: -2.36 Industry: 2.15

P/SALES RATIO (PSR)

0.05

Sector: 2.07 Industry: 0.69

P/BV

-0.51

Sector: 2.24 Industry: 1.97

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-62.69%

Sector: -27.36% Industry: -12.35%

ROE

443.63%

Sector: -30.63% Industry: -23.95%

ROIC

-55.62%

Sector: -416.26% Industry: -111.32%

NET MARGIN

-41.68%

Sector: -28.68% Industry: -11.07%

GROSS MARGIN

33.01%

Sector: 43.81% Industry: 31.35%

OPERATING MARGIN

-35.86%

Sector: -24.80% Industry: -8.00%

P/EBITDA

-0.15

Sector: -0.47 Industry: 2.63

P/EBIT

-0.13

Sector: -2.70 Industry: 0.96

P/ASSET

0.07

Sector: 1.22 Industry: 0.79

BVPS

-0.13

Sector: 3.31 Industry: 5.64

EPS

-0.58

Sector: -0.91 Industry: -0.27

EQUITY RATIO

-0.14

Sector: 0.42 Industry: 0.28

CAGR REVENUE 5 YEARS

15.14%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-10.90%

Sector: - Industry: -

Fundamentals BIOL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	50.06	38.64	77.20%	0.58%	$ 921.68 B	30.99%
ISRG	70.48	11.36	16.12%	0.00%	$ 193.61 B	28.58%
TMO	32.93	4.23	12.84%	0.29%	$ 216.32 B	15.02%
SNY	10.59	1.47	13.90%	4.54%	$ 119.31 B	14.83%
MDT	26.88	0.00	0.00%	2.82%	$ 128.03 B	13.71%
NVS	17.74	5.71	32.16%	2.92%	$ 255.33 B	25.53%
ABT	16.07	4.38	27.26%	1.83%	$ 224.54 B	31.88%
CVS	214.89	1.38	0.64%	3.35%	$ 100.78 B	0.12%
GSK	13.48	4.62	34.29%	3.37%	$ 98.42 B	17.23%
BSX	49.14	0.00	0.00%	0.00%	$ 137.20 B	14.43%
TMDX	46.97	12.14	25.84%	0.00%	$ 4.31 B	16.20%
HCA	17.80	-52.32	-293.84%	0.58%	$ 112.95 B	8.53%
IDXX	54.83	36.09	65.81%	0.00%	$ 56.34 B	24.65%
INMD	6.11	1.40	22.89%	0.00%	$ 914.13 M	41.04%
DHR	45.94	3.15	6.86%	0.54%	$ 160.92 B	14.43%
RMD	25.61	6.02	23.49%	0.66%	$ 36.83 B	27.35%
FMS	16.89	0.84	5.00%	3.34%	$ 13.78 B	3.73%
PHG	112.41	2.04	1.81%	3.33%	$ 25.32 B	1.14%
SYK	45.85	6.19	13.51%	0.95%	$ 134.93 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BIOL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/28/2005	07/12/2005	114,84972458
Dividend	04/25/2005	05/09/2005	114,84972458
Dividend	02/10/2005	02/24/2005	114,84972458
Dividend	12/15/2004	12/29/2004	114,84972458
Dividend	10/13/2004	10/27/2004	114,84972458
Dividend	08/16/2004	08/30/2004	114,84972458

ABOUT THE COMPANY BIOLASE

BIOLASE Inc.

Average user rating I10

4.0 (0 people)

United States

38 years

Founded: 1987

1992

Time since IPO - 33 years

135

Employees

The Company BIOLASE Inc. (United States), is listed on Nasdaq with a market value of $ 2.22 Millions, having an equity of $ -4.33 Millions.

With a total of 135 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 46.09 Millions, which generated a loss in the amount of $ -19.21 Millions.

As for its main indicators, the Company has a P/E ratio of -0.12, a P/BV ratio of -0.51 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BIOL.

Market cap

$ 2.22 Millions

Net worth

$ -4.33 Millions

US$ -4,330,000.00

Assets

$ 30.64 Millions

US$ 30,640,000.00

Total Shares Outstanding

33.00 Millions

33,000,000

Average Daily Trading Volume

$ 132.23 Thousand

US$ 132,229.90

Sector

Health

Industry

Medical Supplies and Equipment

BIOL

BIOL revenue and profits

Financial Results BIOL

DRAG THE FRAME TO SEE MORE DATA

BIOL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.42 67,75% (12M)

P/E

214.89

3.35%

ROE

0.64%

P/BV

1.38

CI - Cigna

$ 274.70 --0,68% (12M)

P/E

11.89

2.16%

ROE

14.63%

P/BV

1.74

CNC - Centene

$ 40.85 --31,25% (12M)

P/E

-3.79

0.00%

ROE

-25.12%

P/BV

0.95

HUM - Humana

$ 268.45 --0,69% (12M)

P/E

24.95

1.32%

ROE

6.95%

P/BV

1.73

SNY - Sanofi

$ 48.68 8,63% (12M)

P/E

10.59

4.54%

ROE

13.90%

P/BV

1.47

HCA - HCA Healthcare

$ 484.77 58,11% (12M)

P/E

17.80

0.58%

ROE

-293.84%

P/BV

-52.32

LLY - Eli Lilly

$ 1,027.51 32,88% (12M)

P/E

50.06

0.58%

ROE

77.20%

P/BV

38.64